Why we don’t do what everyone else does
— on purpose.
The startup world is thriving - from EU Startup and Scaleup strategies, initiatives like Techstars and Hello Tomorrow to generic pitch deck creators and grants consultancies.
​
But most of these follow lean startup logic and one-size-fits-all approaches:
fast validation, quick wins, plug-and-play funding paths with some tools.
Collaborate with us
Startup / Corporate
Whether you are a founder pushing a breakthrough out of the lab or an established company trying to move R&D beyond pilot projects, the challenges follow the same pattern. Deep tech does not fit into the timelines of venture capital or the templates of traditional grant consultancy. Investors want "traction" before the science is validated, CFOs focus on burn rate rather than feasibility, and grants are often treated as a substitute for business models. The result is predictable: 92% deep tech ventures fail, not because the science is flawed, but because the funding logic suffocates it.
At Arise we rebuild that logic from the ground up. We take your technology readiness level as the anchor, map your milestones, and reverse-engineer a capital strategy that matches reality. That means combining non-dilutive grants, patient private capital, and industry partnerships into a sequence that gives your innovation the time it needs. For corporates and SMEs this also means turning internal R&D into a capital lever — transforming IP, pilots, and joint ventures into monetizable outcomes instead of stranded projects.
What you receive is tangible: a multi-year capital roadmap, execution-ready documents, and a capital narrative that aligns equally with evaluators, investors, and industry partners. In practice, this means survival past the valley of death and a direct path toward commercialization at scale.
Institutions / Ecosystems
Universities, accelerators and policy programs are under pressure to prove impact. Yet most rely on generic startup training methods designed for SaaS. The result is that promising ventures are polished for pitches but collapse at TRL 4-6 — exactly where the majority of failures occur. Mentors often lack scientific literacy, governance is built on business optics, and ecosystems measure outputs rather than outcomes.
​
​
Arise partners with institutions and ecosystems to change that equation. Our science-first method, proven across more than a hundred projects with a success rate that outperforms the field, ensures that programs do not simply produce pitch decks without substance but ventures that secure follow-on funding and survive long enough to commercialize. We design program structures that tie TRL milestones to capital and market logic, train stakeholders to evaluate fundability with scientific rigor, offer keynotes and workshops, and provide hands-on support for the ventures you select.
​
​
The benefit is twofold: higher survival rates for impactful ventures and stronger credibility for your institution. You position yourself as the ecosystem that consistently carries science innovation across the valley of death — the one that sets the standard for how deep tech should be built and financed.
Why this approach
Deep Tech Is More Than a Buzzword
Deep tech doesn't iterate fast. It collides with physics, regulation, and scientific uncertainty. Timelines stretch over years. Risk perception is higher. And yet - the impact is exponential, if guided right.
​
Why Standard Tools Fail
Traditional consulting leans on KPIs, storytelling frameworks, and generic capital strategies. These approaches break down when science leads the way. Real innovation demands more than templates - it demands structural thinking.
​
Where We Come In
At Arise, we reverse-engineer fundability from the science up. We don’t force-fit your innovation into startup patterns. We build a custom capital architecture rooted in your TRL, constraints, and endgame.
​
Deep tech requires depth instead of speed. That’s exactly why we exist.